Hofmann Heike, Geier Martina, Marzi Andrea, Krumbiegel Mandy, Peipp Matthias, Fey Georg H, Gramberg Thomas, Pöhlmann Stefan
Chair of Genetics, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Biochem Biophys Res Commun. 2004 Jul 9;319(4):1216-21. doi: 10.1016/j.bbrc.2004.05.114.
The angiotensin converting enzyme 2 (ACE2) has been identified as a receptor for the severe acute respiratory syndrome associated coronavirus (SARS-CoV). Here we show that ACE2 expression on cell lines correlates with susceptibility to SARS-CoV S-driven infection, suggesting that ACE2 is a major receptor for SARS-CoV. The soluble ectodomain of ACE2 specifically abrogated S-mediated infection and might therefore be exploited for the generation of inhibitors. Deletion of a major portion of the cytoplasmic domain of ACE2 had no effect on S-driven infection, indicating that this domain is not important for receptor function. Our results point to a central role of ACE2 in SARS-CoV infection and suggest a minor contribution of the cytoplasmic domain to receptor function.
血管紧张素转换酶2(ACE2)已被确定为严重急性呼吸综合征相关冠状病毒(SARS-CoV)的受体。在此我们表明,细胞系上ACE2的表达与对SARS-CoV S介导感染的易感性相关,这表明ACE2是SARS-CoV的主要受体。ACE2的可溶性胞外域特异性消除了S介导的感染,因此可用于开发抑制剂。删除ACE2胞质域的大部分对S介导的感染没有影响,表明该结构域对受体功能并不重要。我们的结果表明ACE2在SARS-CoV感染中起核心作用,并提示胞质域对受体功能的贡献较小。